- Home
- All Stock List
- NSE
- SMS Lifesciences India Ltd Share Price
SMS Lifesciences India Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap
1,078.00
-62.45 (-5.48%)
-
Outperforms Index
59.43%
Return (1Y)
Beaten Nifty 50 by 54.09%
-
More Volatile
3.54%
Standard Deviation (1Y)
Higher than Nifty 50 by 2.66%
-
Consistent Performer
9/12
Months
beaten Nifty 50
-
AxisDirect View
No View
1,750
626
News & Announcements
-
SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr
13 - Feb - 2025 12:00 | 46 days ago
Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a growth of 17.41% compared with Rs 72.05 crore in Q3 FY24.
In Q3 FY25, the profit before tax (PBT) spiked 81.36% year on year (YoY) to Rs 6.91 crore.
Total expenses added 12.96% YoY to Rs 77.74 crore in the quarter ended 31 December 2024. Cost of materials consumed was at Rs 39.43 crore (up 0.61% YoY), and employee benefits expense was at Rs 14.60 crore (up 9.69% YoY) during the period under review.
On a nine-month basis, the company reported consolidated net profit of Rs 15.24 crore in 9M FY25, compared with net loss of Rs 0.14 crore posted in 9M FY24. Revenue from operations jumped 18.35% YoY to Rs 255.61 crore in 9M FY25.
Meanwhile, the board has approved the reappointment of Veeravenkata Satyanarayana Murthy Talluri as managing director (MD) of the company for a further period of 3 consecutive year’s w.e.f. 1 June 2025.
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents, and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API), and intermediates.
Powered by Capital Market - Live News
-
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
46 days ago
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
13 - Feb - 2025 12:00 | 46 days ago
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 84.60 72.05 17 OPM % 15.07 12.89 - PBDT 10.67 7.54 42 PBT 6.92 3.81 82 NP 5.47 4.30 27 Powered by Capital Market - Live News
-
-
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
46 days ago
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
13 - Feb - 2025 12:00 | 46 days ago
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 84.60 72.05 17 OPM % 15.07 12.89 - PBDT 10.67 7.54 42 PBT 6.92 3.81 82 NP 5.47 4.30 27 Powered by Capital Market - Live News
-
-
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
138 days ago
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
13 - Nov - 2024 12:00 | 138 days ago
Net profit of SMS Lifesciences India rose 586.76% to Rs 4.67 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales rose 13.28% to Rs 78.46 crore in the quarter ended September 2024 as against Rs 69.26 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 78.46 69.26 13 OPM % 10.91 11.45 - PBDT 8.47 5.39 57 PBT 4.70 1.66 183 NP 4.67 0.68 587 Powered by Capital Market - Live News
-
SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr
13 - Feb - 2025 12:00 | 46 days ago
Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a growth of 17.41% compared with Rs 72.05 crore in Q3 FY24.
In Q3 FY25, the profit before tax (PBT) spiked 81.36% year on year (YoY) to Rs 6.91 crore.
Total expenses added 12.96% YoY to Rs 77.74 crore in the quarter ended 31 December 2024. Cost of materials consumed was at Rs 39.43 crore (up 0.61% YoY), and employee benefits expense was at Rs 14.60 crore (up 9.69% YoY) during the period under review.
On a nine-month basis, the company reported consolidated net profit of Rs 15.24 crore in 9M FY25, compared with net loss of Rs 0.14 crore posted in 9M FY24. Revenue from operations jumped 18.35% YoY to Rs 255.61 crore in 9M FY25.
Meanwhile, the board has approved the reappointment of Veeravenkata Satyanarayana Murthy Talluri as managing director (MD) of the company for a further period of 3 consecutive year’s w.e.f. 1 June 2025.
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents, and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API), and intermediates.
Powered by Capital Market - Live News
-
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
46 days ago
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
13 - Feb - 2025 12:00 | 46 days ago
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 84.60 72.05 17 OPM % 15.07 12.89 - PBDT 10.67 7.54 42 PBT 6.92 3.81 82 NP 5.47 4.30 27 Powered by Capital Market - Live News
-
-
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
138 days ago
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
13 - Nov - 2024 12:00 | 138 days ago
Net profit of SMS Lifesciences India rose 586.76% to Rs 4.67 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales rose 13.28% to Rs 78.46 crore in the quarter ended September 2024 as against Rs 69.26 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 78.46 69.26 13 OPM % 10.91 11.45 - PBDT 8.47 5.39 57 PBT 4.70 1.66 183 NP 4.67 0.68 587 Powered by Capital Market - Live News
-
SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr
13 - Feb - 2025 12:00 | 46 days ago
Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a growth of 17.41% compared with Rs 72.05 crore in Q3 FY24.
In Q3 FY25, the profit before tax (PBT) spiked 81.36% year on year (YoY) to Rs 6.91 crore.
Total expenses added 12.96% YoY to Rs 77.74 crore in the quarter ended 31 December 2024. Cost of materials consumed was at Rs 39.43 crore (up 0.61% YoY), and employee benefits expense was at Rs 14.60 crore (up 9.69% YoY) during the period under review.
On a nine-month basis, the company reported consolidated net profit of Rs 15.24 crore in 9M FY25, compared with net loss of Rs 0.14 crore posted in 9M FY24. Revenue from operations jumped 18.35% YoY to Rs 255.61 crore in 9M FY25.
Meanwhile, the board has approved the reappointment of Veeravenkata Satyanarayana Murthy Talluri as managing director (MD) of the company for a further period of 3 consecutive year’s w.e.f. 1 June 2025.
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents, and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API), and intermediates.
Powered by Capital Market - Live News
-
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
46 days ago
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
13 - Feb - 2025 12:00 | 46 days ago
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 84.60 72.05 17 OPM % 15.07 12.89 - PBDT 10.67 7.54 42 PBT 6.92 3.81 82 NP 5.47 4.30 27 Powered by Capital Market - Live News
-
-
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
46 days ago
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
13 - Feb - 2025 12:00 | 46 days ago
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 84.60 72.05 17 OPM % 15.07 12.89 - PBDT 10.67 7.54 42 PBT 6.92 3.81 82 NP 5.47 4.30 27 Powered by Capital Market - Live News
-
-
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
138 days ago
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
13 - Nov - 2024 12:00 | 138 days ago
Net profit of SMS Lifesciences India rose 586.76% to Rs 4.67 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales rose 13.28% to Rs 78.46 crore in the quarter ended September 2024 as against Rs 69.26 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 78.46 69.26 13 OPM % 10.91 11.45 - PBDT 8.47 5.39 57 PBT 4.70 1.66 183 NP 4.67 0.68 587 Powered by Capital Market - Live News
Stock Trivia
FII shareholding in SMS Lifesciences India Ltd has decreased by -100% since past 3 Months
SMS Lifesciences India Ltd has opened at 1105.4 i.e -3.07% below then yesterday's closing price of 1140.45
FII shareholding in SMS Lifesciences India Ltd has decreased by -100% since past 3 Months
SMS Lifesciences India Ltd has opened at 1105.4 i.e -3.07% below then yesterday's closing price of 1140.45
FII shareholding in SMS Lifesciences India Ltd has decreased by -100% since past 3 Months
SMS Lifesciences India Ltd has opened at 1105.4 i.e -3.07% below then yesterday's closing price of 1140.45
